A recent study identified a differential mRNA expression panel consisting of nine genes, in which SPRY2 was upregulated in patients with advanced rectal cancer who did not respond to preoperative chemoradiotherapy (PCRT) [53]. Here, SPRY2 is linked to rectal cancer.